NCT03210740View on ClinicalTrials.gov

Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 6, 2017

Primary Completion Date

February 13, 2018

Study Completion Date

April 24, 2018

Conditions
Actinic Keratosis
Interventions
DRUG

AM001 Cream, 7.5%

Active Cream

DRUG

Vehicle Cream

Placeo

Trial Locations (1)

27262

AmDerma Pharmaceuticals, LLC, High Point

Sponsors

Lead Sponsor

AmDerma
All Listed Sponsors
lead

AmDerma

INDUSTRY

NCT03210740 - Safety and Efficacy Study of AM001 Cream in the Treatment of Actinic Keratosis | Biotech Hunter | Biotech Hunter